促销时间表 Clearside Biomedical, Inc.
先进的时间表
简单图表
关于公司 Clearside Biomedical, Inc.
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. Clearside Biomedical, Inc. 更多详情| IPO date | 2016-06-02 |
|---|---|
| ISIN | US1850631045 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://clearsidebio.com |
| Цена ао | 1.02 |
| 每日价格变化: | -7.77% (1.03) |
|---|---|
| 每周价格变化: | -5.47% (1.005) |
| 每月价格变化: | +5.56% (0.9) |
| 3个月内价格变化: | 0% (0.95) |
| 六个月内的价格变化: | -25.2% (1.27) |
| 每年价格变化: | -37.91% (1.53) |
| 3年内价格变化: | -60.58% (2.41) |
| 5年内价格变化: | -63.04% (2.57) |
| 年初以来价格变化: | -4.5% (0.9948) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Vanguard Group Inc | 2176316 | 2.91 |
| Carmignac Gestion | 2132744 | 2.85 |
| Blackrock Inc. | 759743 | 1.02 |
| Geode Capital Management, LLC | 490690 | 0.66 |
| Renaissance Technologies, LLC | 384689 | 0.51 |
| State Street Corporation | 193363 | 0.26 |
| Bridgeway Capital Management, Inc. | 175600 | 0.24 |
| First Manhattan Company | 175000 | 0.23 |
| Johnson & Johnson | 169629 | 0.23 |
| Morgan Stanley | 144434 | 0.19 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.02367 | 17.09 | 1.54048 |
| 0.02 | 17.09 | 1.54 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D. | President, CEO & Director | 836.15k | 1952 (73 年) |
| Mr. Charles A. Deignan | Chief Financial Officer | 568.68k | 1964 (61 年) |
| Ms. Jenny R. Kobin | Head of Investor Relations | N/A | 1967 (58 年) |
| Mr. Rick McElheny | Senior Vice President of Corporate Development & Alliance Management | N/A | |
| Mr. Rafael V. Andino | Senior Vice President of Engineering & Manufacturing | N/A | 1965 (60 年) |
| Ms. Susan L. Coultas Ph.D. | Chief Clinical Officer | N/A | |
| Mr. Leslie B. Zacks | Secretary | N/A | 1969 (56 年) |
| Dr. Ngai Hang Chong FRCOphth, FRCS, M.B.A., M.D. | Chief Medical Officer |
地址: United States, Alpharetta. GA, 900 North Point Parkway - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://clearsidebio.com
网站: https://clearsidebio.com
